Cardinal Health, Inc.

Cardinal Health, Inc.

CAHNYSEHealthcare
$254.06
up +0.35 (+0.14%)

1-Year Price

+60.87% past year
Cardinal Health, Inc. (CAH) 1-year price chart: up 60.87% from $157.93 on Oct 2025 to $254.06 on Oct 2026. Closing range $153.27 to $254.06.

EquityGlimpse Score

Overall
5.5/10
No Moat

No clear sustainable competitive advantage detected.

Growth
5

Valuation, profitability, financial health, dividend and sentiment scores for Cardinal Health, Inc. (CAH) are available to EquityGlimpse members.

Market Cap
58.83B
P/E Ratio
32.68
EPS
$7.26
52W High
$258.3
52W Low
$155.84
Volume
1.26M
Beta
0.5
Dividend Yield
0.88%
Fair value estimate: sign up to see
Is CAH over- or undervalued? Run DCF and multiples models on EquityGlimpse.
See fair value

Key Financial Metrics

Price to Sales
0.22
Price to Book
-19.45
EV/EBITDA
17.58
Free CF per Share
$19.17
Op. CF per Share
$21.92
Debt to Equity
-3.45
Gross Margin
3.84%
Net Margin
0.67%

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

CEO
Jason Hollar
Industry
Medical - Distribution
Employees
61,344
IPO Date
1983-08-04
Country
US
Unlock Full Analysis

Get the complete picture on Cardinal Health, Inc.

Sign up for EquityGlimpse to access deep fundamental data, AI reports, valuation models, and real-time tracking for CAH and 8,500+ other stocks.

30 Years of Financials
Income statements, balance sheets, and cash flows with 70+ interactive charts
AI-Powered Analysis
Generate professional research reports with 15+ AI models
DCF Valuation
Run discounted cash flow models with customizable assumptions
Portfolio Tracking
Track real-time P&L, sector allocation, and dividend projections
Earnings Intelligence
Surprise tracking, revision momentum, and whisper estimates
Insider & Congress Trades
Monitor what insiders and Congress members are buying and selling

Starting at $8.25/month. 7-day free trial. Cancel anytime.